| Enhancer ID: | E_02_0192 |
| Species: | human |
| Position : | chr17:39685586-39687586 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Cancer |
| Pubmed ID: | 31588020 |
| Enhancer experiment: | PCR,Western blot |
| Enhancer experiment description: | However, the National Comprehensive Can_x0002_cer Network guidelines for non-small cell lung cancer (NSCLC) recommend that newly diagnosed patients undergo broad mo_x0002_lecular profiling to detect ERBB2 mutations (Ettinger et al., 2018). |
| Target gene : | ERBB2(CD340,HER-2,HER-2/neu,HER2,MLN19,NEU,NGL,TKR1) |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | However, the National Comprehensive Can_x0002_cer Network guidelines for non-small cell lung cancer (NSCLC) recommend that newly diagnosed patients undergo broad mo_x0002_lecular profiling to detect ERBB2 mutations (Ettinger et al., 2018). |
| TF name : | -- |
| TF experiment: | PCR,Western blot |
| TF experiment description: | However, the National Comprehensive Can_x0002_cer Network guidelines for non-small cell lung cancer (NSCLC) recommend that newly diagnosed patients undergo broad mo_x0002_lecular profiling to detect ERBB2 mutations (Ettinger et al., 2018). |
| Enhancer function : | However, the National Comprehensive Can_x0002_cer Network guidelines for non-small cell lung cancer (NSCLC) recommend that newly diagnosed patients undergo broad mo_x0002_lecular profiling to detect ERBB2 mutations (Ettinger et al., 2018). |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
However, the National Comprehensive Can_x0002_cer Network guidelines for non-small cell lung cancer (NSCLC) recommend that newly diagnosed patients undergo broad mo_x0002_lecular profiling to detect ERBB2 mutations (Ettinger et al., 2018). |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|